CTI Biopharma reported $435K in Interest Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Baxter International BAX:US USD 5M 1000K
CTI Biopharma CTIC:US USD 435K 223K
Cytori Therapeutics CYTX:US USD 48K 29K
Eli Lilly LLY:US USD 20.1M 9.9M
Geron GERN:US USD 852K 522K